Kyooseob Ha

Kyooseob Ha

Professor (Partner), UBC Department of Psychiatry, Division of Neuroscience and Translational Psychiatry

Staff Psychiatrist, Coastal Community of Care, Lions Gate Hospital

Member, UBC Mood Disorders Program

Email: kyooseob.ha@ubc.ca

Short Biography

Dr. Ha is an internationally renowned expert on the early diagnosis of bipolar disorders and major depressive disorder. Prior to arriving at UBC, he was a Professor of Psychiatry at Seoul National University (SNU), running its Mood Disorders Clinic and Affective Neuroscience Lab. His concern includes clinical research on phenomenology, long-term course, psychopharmacology, and biological markers, including brain imaging and proteomics, of mood disorders and suicide. He also devoted himself to early detection and psychoeducation for bipolar patients. He has served as the Vice-President of the International Society for Bipolar Disorders and Chairman of the Asian Network of Bipolar Disorder. He also served as the President of the Korean Association for Suicide Prevention and has led the movement for legislation to prevent suicide and the establishment of the Korea Suicide Prevention Center. Dr. Ha has authored more than 150 peer-reviewed papers in international journals.

Research Focus

  • Key research interests include early diagnosis of bipolar II disorder among depressed subjects, using clinical characteristics and biological findings including brain imaging, physiology, and proteomics.
  • Efforts to develop an integrative analysis of longitudinal clinical data and biological characteristics, including proteomics, for early prediction of drug response and suicidal risk in patients with bipolar disorders and major depressive disorders
  • One of S. Korea’s foremost experts on suicide, having led multiple epidemiological studies on this phenomenon in his home country, where the suicide rate is one of the highest among industrialized nations.

Clinical Focus

  • Bipolar disorders – clinical interests include early diagnosis of bipolar II disorder among depressed, pharmacotherapy, pros and cons of using antidepressants, development of application of psychoeducation, and long-term stabilization
  • Major depressive disorder – clinical interests include pharmacotherapy, prevention of recurrence, and prediction of conversion to bipolar disorders

Significant Accomplishments & Professional Contribution

  • Professor, Department of Psychiatry, Seoul National University, 1995 to 2021
  • President of the Korean Association for Suicide Prevention, 2010 to 2013
  • Director of the Korea National Center for Mental Health, 2013 to 2016
  • Chairman of the Korea Mental Health Commission to the Ministry of Health and Welfare, 2014 to 2017
  • Chair of Department of Psychiatry, Seoul National University, 2016 to 2017
  • International Society for Bipolar Disorder (ISBD) Scholars Award for Clinical Advancement in Asia, June 4, 2015
  • Order of Health Merit for Enhancement of Mental Health, Republic of Korea, April 7, 2016
  • Mogens Schou Award for Public Service and Advocacy, International Society for Bipolar Disorders, March 7, 2018
  • Founding Chairman of the East Asian Bipolar Forum, 2007 to 2013
  • Chairman of the Asian Network of Bipolar Disorder, 2010 to 2013
  • Vice-President of the International Society for Bipolar Disorders, 2010 to 2014
  • Editorial Board Member, International Review of Psychiatry (2011-2022)
  • Editorial Board member, General Psychiatry (2011-2022)
  • Editorial Board Member, International Journal of Bipolar Disorder (2012-2022)